Authors
Latest:
BTKi Treatment ParadigmNeurology experts discuss where BTKi’s fit in the multiple sclerosis treatment continuum.
Latest:
Paul Newhouse, MD: Muscarinic Agonists in Alzheimer TreatmentThe Jim Turner Chair in Cognitive Disorders at the Vanderbilt University School of Medicine shared how the previous muscarinic agonists have better informed the development of this investigational agent, VU319.
Latest:
The “Grave Threat” Posed by the Shortage of NeurologistsWith the physician deficit projected to grow larger within a decade, this global challenge has become a major focus of large organizations and medical societies.
Latest:
Peii Chen, PhD: Addressing Spatial Neglect After StrokeThe senior research scientist at Kessler Foundation offered her personal experience in treating spatial neglect in patients with stroke and potential future treatments on the way.
Latest:
NeurologyLive® Friday 5 — October 4, 2024Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 4, 2024.
Latest:
John Corboy, MD: The DISCO-MS TrialThe professor of neurology at Colorado University spoke about the ongoing phase IV trial to determine the safety of DMT discontinuation in MS.
Latest:
Neurology on the Hill: My Role as an Advocate for NeurologyNeuro-oncology fellow Ashley Aaroe recounts her experience at Neurology on the Hill, advocating for important changes in neurology health care.
Latest:
Steve Chung, MD: Cannabidiol in Tuberous Sclerosis ComplexThe neurologist at Banner-University Medicine Neuroscience Institute offered his perspective on data from an open-label safety assessment of cannabidiol (Epidiolex) in the treatment of tuberous sclerosis complex.
Latest:
2022 SMA Research & Clinical Care Meeting: What to ExpectMary Schroth, MD, and Jacqueline Glascock, PhD, of Cure SMA, share their perspectives on the upcoming annual meeting.
Latest:
Karen J. Nolan, PhD: Functional Implementation of Robotics in NeurorehabilitationThe senior research scientist in the Center for Mobility and Rehabilitation Engineering Research at Kessler Foundation spoke to the research being done into the functional implementation of exoskeletons in neurorehabilitation.
Latest:
Shaun Hussain, MD, MS: Exploring the Connection Between Autism and Infantile SpasmsThe director of Infantile Spasms Program at UCLA Mattel Children’s Hospital discussed why learning more about patients with infantile spasms may lead to further breakthroughs on the origins of autism spectrum disorder.
Latest:
Treatment Challenges for Migraine During Pregnancy: Brian Grosberg, MD, FAHSThe medical director of the Hartford healthcare Headache Center in Connecticut discussed the significance of findings from a study assessing migraine during pregnancy. [WATCH TIME: 4 minutes]
Latest:
Jerome Engel, Jr., MD, PhD on Referring Patients to Epilepsy CentersThe Director of the UCLA Seizure Disorder Center explained the importance of referring patients with seizures to epilepsy centers.
Latest:
Shai Efrati, MD: Assessing Hyperbaric Oxygen Therapy for NeurodegenerationThe director of the Sagol Center for Hyperbaric Medicine and Research at Yitzhak Shamir Medical Center offers takeaways on hyperbaric oxygen therapy.
Latest:
Managing Psychosis in Parkinson Disease: Challenges and OpportunitiesAlthough the indication of pimavanserin has provided some relief, more work remains to improve how physicians diagnose, treat, and manage psychosis symptoms.
Latest:
Bruton Tyrosine Kinase Inhibitors: A New Hope for the Management of Progression in MS?Several therapies are progressing through the development pipeline and have shown promising data, setting up the multiple sclerosis treatment toolbox for possible expansion in coming years.
Latest:
Thomas Leist, MD: Resetting the Immune System With CladribineThe director of the Comprehensive Multiple Sclerosis Center at Thomas Jefferson University discussed the concept of lymphocyte depletion to reset the immune system.
Latest:
Postictal Generalized EEG Suppression as a Biomarker for SUDEP: Nancy R. Foldvary-Schaefer, DO, FAANThe director of the Sleep Disorders Center and staff in the Epilepsy Center at Cleveland Clinic discussed how additional sensors in seizure monitoring for patients with epilepsy may help better manage the risk of SUDEP. [WATCH TIME: 3 minutes]
Latest:
Early Treatment Response and Safety Profile of AXS-05 in Phase 3 ACCORD Trial: Anton P. Porsteinsson, MDThe director of the Alzheimer's Disease Care, Research and Education Program at the University of Rochester discussed treatment response and safety findings from the phase 3 ACCORD study assessing AXS-05 for agitation in Alzheimer disease. [WATCH TIME: 6 minutes]
Latest:
Generational Perspective in Multiple Sclerosis CareDr Krieger, Dr Brandstadter, and Dr Lublin discuss the advances made in recognizing and managing multiple sclerosis over the last few decades and the challenges that remain.
Latest:
Dravet Syndrome DiagnosisScott Perry, MD, discusses how Dravet syndrome is diagnosed through a combination of clinical observation, genetic testing, and phenotypic evaluation, emphasizing the challenges and importance of early diagnosis to improve patient outcomes.
Latest:
Richard Rudick, MD: The CogEval App in Clinical PracticeThe goal of the free application is to make cognitive assessments routine in multiple sclerosis treatment.
Latest:
Isabelle Lambert, MD: Spike, Spindle Frequency in Hippocampus During NREM Affect Long-Term MemoryImpairment of physiological spindle activity in the hippocampus during NREM sleep by interictal epileptic activities may have negative consequences on long-term memory consolidation.
Latest:
Annette Langer-Gould, MD, PhD: Lowering Postpartum MS Relapse Rates With BreastfeedingThe regional lead in clinical and translational neuroscience at Kaiser Permanente discussed subgroup findings from a study of pregnancy in women with MS which suggested that breastfeeding in the postpartum period can drastically decrease the risk of disease relapse.
Latest:
Partnering Clinicians With Parents as a Motivator for Pediatric Epilepsy Research: Zachary Grinspan, MD, MSThe pediatric epilepsy specialist at Weill Cornell Medicine in New York City spoke on how meetings such as the 2022 AES Conference bring clinicians together as well as how parents motivate them to advance pediatric epilepsy research. [WATCH TIME: 6 minutes]
